Is CRO Consolidation Good For Pharma?

Big CROs get bigger—how will that affect sponsors? Consolidation continues in the CRO space, with the acquisition of Chiltern by LabCorp being just the latest example of top CROs expanding and increasing their breadth of offerings. As large CROs continue to acquire smaller competitors, can sponsor companies expect to benefit from this development? I recently … Continued

Respondents Average 3.2 Small Molecule Sterile Injectables in Their Development Pipelines

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – August 8, 2017 –  Industry Standard Research’s (ISR’s) Small Molecule Sterile Injectable Drug Product Manufacturing Market Overview and Outlook report looks specifically at the portfolios and pipelines of small molecule sterile injectable outsourcers to gauge future demand among outsourcers, to understand how contract manufacturers are selected … Continued

Low cost continues to gain importance among both development and commercial small molecule outsourcers

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – July 25, 2017 –  Industry Standard Research’s (ISR’s) Development vs Commercial Outsourced Manufacturing Practices: Small Molecule report offers insight into how the industry, using different outsourcing scenarios, prioritizes CMO selection attributes. Whether selecting a CMO for the first time or for the 50th … Continued

Development-stage drug product outsourcers highly value Right-first-time measurements

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – July 25, 2017 –  Industry Standard Research’s (ISR’s) Development vs Commercial Outsourced Manufacturing Practices: Biologics report offers insight into how respondents in different outsourcing scenarios prioritize different CMO selection attributes. Whether selecting a CMO for the first time or for the 50th time, this … Continued

Traditional Tablets Will Lose Market Share Due to Increased Use of Modified Release Technologies

Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC – May 31, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Oral Dosage Forms Market Overview and Outlook report offers details on how industry utilization rates of seventeen different oral dosage forms will shift over the next five years as new technologies and capabilities … Continued

INC Research, PPD Shine in ISR’s 2017 Phase IV CRO Quality Benchmarking Report

Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC – May 31, 2017 – Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking – Phase IV Service Providers (9th Edition), containing findings focused on service provider selection and evaluation. Kevin Olson, CEO, explains, “Each Phase IV clinical outsourcing need is unique. … Continued

Celerion, SGS Life Sciences Stand-out Performers in ISR’s 2017 Phase I Quality Benchmarking Report

The Phase I CROs received high marks in organization and staff factors Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC – May 18, 2017 – Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking – Phase I Service Providers (9th Edition), containing findings focused on service provider selection and evaluation. Kevin Olson, … Continued

Experiential Data Sheds Light On The CRO Selection Process

Vice President of Market Research at Industry Standard Research Rebecca McAvoy explains how our experiential user data can be used to pick the best service provider for your unique needs. From Life Science Leader: For decision makers whose companies have sophisticated outsourcing processes, using peer-based data can assist in evaluating CROs. Those at larger, more … Continued

Medpace and DCRI-Duke exceed expectations in Phase II/III Staff Characteristics

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, N.C. – April 26, 2017 – Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking – Phase II/III Service Providers (9th Edition), containing findings focused on service provider selection and evaluation. Kevin Olson, CEO, explains, “This report offers critical information for those … Continued

Pharma Industry Lacks Consensus On Key Attribute Of A Sponsor-CMO Relationship

VP of Market Research at Industry Standard Research Kate Hammeke discusses how greater diversity in selection criteria leads to a cloudy decision-making process because no specific criterion dominates the CMO selection decision.   To help Life Science Leader’s readers understand more about these industry peers, ISR asked participants in the research to prioritize a list … Continued

ISR Projects Strong Growth in the CRO Market

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – March 7, 2017 – Industry Standard Research (ISR) today announced the release of its latest CRO market report titled; 2017 Edition of the CRO Market Size Projections: 2016-2021. This report provides readers with a comprehensive assessment of the global market for CRO services. … Continued

CMOs need to increase awareness of offerings, ISR reports

Outsourcers know what they want, do they know your CDMO provides it? A “new set of leaders” emerged in the contract manufacturing organization (CMO) industry over the past year, though many remain unheard of, according to a recent report. Kate Hammeke, Vice President, Market Research, Industry Standard Research, told us drug product outsourcers are consistent … Continued

Big Pharma CMOs capture strongest performance ratings for small molecule API manufacturing

Manufacturers benefit from having innovators as their parent companies Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 9, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Small Molecule API Contract Manufacturer Quality Benchmarking report reveals that the top-performing CMOs relative to expectations, and based on customer feedback on recent … Continued

Regulatory history and reliable on-time delivery beat cost and capacity as the most important selection attributes for drug product CMOs

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 8, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Drug Product Contract Manufacturer Quality Benchmarking report reveals that buyers of outsourced drug product manufacturing services value a strong regulatory history and reliable on-time delivery more than low cost when selecting … Continued

Customer loyalty scores for biologic API contract manufacturers slip

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 8, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Biologic API Contract Manufacturer Quality Benchmarking report indicates that buyers of outsourced biologic API services are less loyal to the CMOs they use compared to one year ago. The report includes … Continued

ISR CUSTOMERS